Health

Researchers showed that the biochemical working of this drug molecule points to its promise in the treatment of COVID-19. The paper elaborates on the rationale of repurposing this drug for treating COVID-19 patients. Since the repurposed drug has gone through the clinical development process for the treatment of other diseases and has already been tested for toxicity, many steps in preclinical and early clinical development can be avoided and the drug can be directly tested on COVID-19 subjects in phase-II trials.

National Pharmaceutical Pricing Authority (NPPA) NPPA fixes the price of 81 medicines including off-patent anti-diabetic drugs allowing due benefits of patent expiry to the patients.

The government has shipped 5.86 crore doses of COVID-19 ‘Made in India’ vaccines to 71 countries as grants as well as commercial sales as part of international manufacturer agreements until March 15, 2021, the Parliament was informed on Tuesday.

Prime Minister Mr. Narendra Modi with the true spirit of ‘Vasudhaiva Kutumbakam’ (where the universe is one family) initially supported the access to medicines to more than 150 countries in addition to the availability of COVID-19 vaccines to more than 75 countries in India.

The magnetic resonance imaging (MRI) machine developed by Voxelgrids Innovations Private Limited is entirely made in India and eases some of the primary challenges associated with widespread adoption of MRI – cost, size, and time.